Developing AIDS vaccines has been a frustrating business. A vaccine that triggers immune responses that effectively control early infection by the simian counterpart of HIV in macaques seems promising. See Letter p.523
References
Johnson, W. E. & Desrosiers, R. C. Annu. Rev. Med. 53, 499–518 (2002).
Barouch, D. H. Nature 455, 613–619 (2008).
Hansen, S. G. et al. Nature 473, 523–527 (2011).
Sallusto, F., Mackay, C. R. & Lanzavecchia, A. Annu. Rev. Immunol. 18, 593–620 (2000).
Moss, P. & Khan, N. Hum. Immunol. 65, 456–464 (2004).
Robinson, H. L. & Amara, R. R. Nature Med. 11, S25–S32 (2005).
Haase, A. T. Nature 464, 217–223 (2010).
Hansen, S. G. et al. Nature Med. 15, 293–299 (2009).
Heineman, T. C. et al. J. Infect. Dis. 193, 1350–1360 (2006).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, R. Persistence pays off. Nature 473, 456–457 (2011). https://doi.org/10.1038/473456a
Published:
Issue Date:
DOI: https://doi.org/10.1038/473456a
- Springer Nature Limited